Q-omics provides the consensus-scored FAM138D profile across patient tissues and cancer cell-line models. FAM138D expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, FAM138D RNA expression shows 3,075 significant pathway-activity associations, with the highest sampling consensus in KIRC. Together, these results highlight KIRC as cancer lineages where FAM138D shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.